Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Appointed CFO
|
|
GILEAD SCIENCES, INC. (GILD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/01/2018 |
BW
| Gilead Sciences Announces First Quarter 2018 Financial Results |
| 04/17/2018 |
BW
| Gilead Sciences to Release First Quarter 2018 Financial Results on Tuesday, May 1, 2018 |
| 02/06/2018 |
BW
| Gilead Sciences Announces Fourth Quarter and Full Year 2017 Financial Results |
| 01/23/2018 |
BW
| Gilead Sciences to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, February 6, 2018 |
| 12/21/2017 |
BW
| Gilead Sciences to Present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8 |
| 10/26/2017 |
BW
| Gilead Sciences Announces Third Quarter 2017 Financial Results |
| 10/12/2017 |
BW
| Gilead Sciences to Release Third Quarter 2017 Financial Results on Thursday, October 26, 2017 |
| 09/05/2017 |
BW
| Gilead Sciences to Present at the Morgan Stanley Global Healthcare Conference on Monday, September 11 |
| 09/01/2017 |
BW
| Gilead Sciences to Present at Citi's 12th Annual Biotech Conference on Wednesday, September 6 |
| 07/26/2017 |
BW
| Gilead Sciences Announces Second Quarter 2017 Financial Results |
| 07/12/2017 |
BW
| Gilead Sciences to Release Second Quarter 2017 Financial Results on Wednesday, July 26, 2017 |
| 06/01/2017 |
BW
| Gilead Sciences to Present at the Goldman Sachs 38th Annual Global Healthcare Conference on Thursday, June 15 |
| 05/30/2017 |
BW
| Gilead Sciences to Present at the 37th Annual William Blair Growth Stock Conference on Tuesday, June 13 |
| 05/02/2017 |
BW
| Gilead Sciences Announces First Quarter 2017 Financial Results |
| 04/18/2017 |
BW
| Gilead Sciences to Release First Quarter 2017 Financial Results on Tuesday, May 2, 2017 |
| 02/08/2017 |
BW
| Gilead Sciences to Present at the RBC Capital Markets 2017 Global Healthcare Conference on Wednesday, February 22 |
| 02/07/2017 |
BW
| Gilead Sciences Announces Fourth Quarter and Full Year 2016 Financial Results |
| 08/15/2011 |
BW
| Gilead's Investigational Antiretroviral Quad Regimen Meets 48-Week Primary Objective in Pivotal Phase 3 Clinical Study 102 |
| 07/20/2011 |
BW
| Gilead's Investigational Antiretroviral Elvitegravir Once Daily Non-Inferior to Raltegravir Twice Daily at 48 Weeks |
| 07/19/2011 |
BW
| Gilead Sciences to Release Second Quarter 2011 Financial Results on Tuesday, July 26, 2011 |
| 07/12/2011 |
BW
| Gilead Expands Access Program for Medications in Developing World |
| 06/28/2011 |
BW
| Gilead Sciences Announces Agreement With Tibotec Pharmaceuticals to Develop and Commercialize a New Fixed-Dose Combination of Cobicistat and Prezista® |
| 06/08/2011 |
BW
| Gilead Sciences to Present at the 31st Annual William Blair & Company Growth Stock Conference on Wednesday, June 15 |
| 05/31/2011 |
BW
| Gilead Sciences to Present at Two Upcoming Investor Conferences |
| 04/29/2011 |
BW
| Gilead Sciences to Present at the Deutsche Bank 36th Annual Health Care Conference on Tuesday, May 3 |
| 04/27/2011 |
BW
| Gilead Appoints Dr. Muzammil M. Mansuri as Senior Vice President, Research and Development Strategy and Corporate Development |
| 04/20/2011 |
BW
| Gilead Sciences Announces First Quarter 2011 Financial Results |
| 04/20/2011 |
BW
| Gilead and MicroDose Therapeutx Announce License and Collaboration Agreement to Develop MDT-637 for Treatment of Respiratory Syncytial Virus |
| 04/13/2011 |
BW
| Gilead Sciences to Release First Quarter 2011 Financial Results on Wednesday, April 20, 2011 |
| 03/30/2011 |
BW
| Yale and Gilead Sciences Announce Cancer Research Collaboration |
| 03/23/2011 |
BW
| Gilead Prices $1 Billion of Senior Unsecured Notes |
| 03/23/2011 |
BW
| Gilead to Offer Senior Notes |
| 03/23/2011 |
BW
| Phase III Clinical Trial of Gilead's Investigational Elvitegravir Meets 48-Week Primary Objective |
| 03/11/2011 |
BW
| Gilead Recommends Rejection of Mini-Tender Offer By TRC Capital Corporation |
|
|
|